Nearly 500,000 tested for viral hepatitis in Kyrgyzstan over six months

Kyrgyzstan conducted extensive testing for viral hepatitis in the first six months of 2026, with nearly half a million people screened. The Republican Center for the Control of Hemocontact Viral Hepatitis and HIV reported that over 235,000 individuals were tested for hepatitis B, more than 234,000 for hepatitis C, and over 20,000 for hepatitis D.

Currently, 6,229 patients are receiving treatment for viral hepatitis B, and 3,244 patients are undergoing treatment for a coinfection of viral hepatitis B and D. For viral hepatitis C, 7,541 patients are receiving treatment, with 6,573 having successfully completed their therapy and achieved a sustained virological response.

Health experts emphasize the critical importance of early diagnosis and treatment, as viral hepatitis B and C can remain asymptomatic for extended periods. Without timely intervention, these infections can progress to severe liver diseases, including cirrhosis and liver cancer. Early detection significantly improves treatment outcomes and prevents complications.

In Kyrgyzstan, essential services such as testing for viral hepatitis B and C, vaccination against hepatitis B, and treatment for patients with chronic hepatitis are provided free of charge. The country observes World Hepatitis Day annually on July 28 to raise awareness about the disease, promote preventive measures, highlight the importance of timely testing, and inform the public about available treatments.